AMRH

8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

424B5 - Enveric Biosciences, Inc. (0000890821) (Filer)

8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)

SC 13G - Enveric Biosciences, Inc. (0000890821) (Subject)

SC 13G - Enveric Biosciences, Inc. (0000890821) (Subject)

8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

8-K/A - Enveric Biosciences, Inc. (0000890821) (Filer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

3 - Enveric Biosciences, Inc. (0000890821) (Issuer)

8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

8-K - Enveric Biosciences, Inc. (0000890821) (Filer)

NAPLES, Fla., Dec. 31, 2020 /PRNewswire/ -- Enveric Biosciences, Inc. (NASDAQ: ENVB) ("Enveric" or the "Company"), formerly AMERI Holdings, Inc. (NASDAQ: AMRH), a patient-centric biotechnology company endeavoring to enhance the lives of those who are adversely affected by the side effects of Cancer Treatments with novel cannabinoid medicines, announced the completion of the previously announced spin-off of the IT services business of the Company and the tender offer, whereby the Company purchased all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Company common stock, or if applicable, shares of Company preferred stock., and Jay Pharma became

25-NSE - AMERI Holdings, Inc. (0000890821) (Subject)

ATLANTA, Dec. 30, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced a 1-for-4 reverse split of its common stock, effective as of 4:02 pm Eastern Time, December 30, 2020 (the "Reverse Stock Split"). As previously announced, at the special meeting of stockholders held on December 29, 2020, Ameri's stockholders approved all proposals to complete the proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement a

ATLANTA, Dec. 29, 2020 /PRNewswire/ -- AMERI Holdings, Inc. (NASDAQ: AMRH) ("Ameri", the "Company"), announced the voting results of the Special Meeting of stockholders that was held today. Based on the report from the Inspector of Elections, Ameri obtained sufficient votes for each proposal required to complete the previously announced proposed tender offer (the "Offer"), whereby Ameri will purchase all of the outstanding common shares of Jay Pharma Inc. ("Jay Pharma") in exchange for shares of Ameri common stock, or if applicable, shares of Ameri preferred stock, at the exchange ratio set forth in the Tender Offer Support Agreement and Termination of Amalgamation Agreement dated August

8-K - AMERI Holdings, Inc. (0000890821) (Filer)

S-4MEF - AMERI Holdings, Inc. (0000890821) (Filer)

8-K - AMERI Holdings, Inc. (0000890821) (Filer)

425 - AMERI Holdings, Inc. (0000890821) (Subject)